SCHEMBL10034860

SCHEMBL10034860

Cc1nccn1-c1ccc2nc(-c3ccc(Oc4ccc(F)cc4)cc3)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 8/20 0.53
MAOB P27338 8/20 0.53
SCN4A P35499 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
MIF P14174 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIK3CA P42336 1/20 0.37
DHODH Q02127 2/20 0.37
SCN9A Q15858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13674802 0.90 MAOA (0.56) MAOAMAOBKDM4EMEN1ALDH1A1
SCHEMBL727724 0.86 MAOA (0.63) MAOAMAOBKDM4EMEN1ALDH1A1
SCHEMBL2357840 0.85 MAOA (0.48) MAOAMAOBMIFCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL1898447 0.85 MAOA (0.61) MAOAMAOBKDM4EMEN1ALDH1A1
SCHEMBL12669374 0.81 MAOA (0.67) MAOAMAOBALDH1A1HPGDCYP3A4
Hydrochloric Acid SCHEMBL1897625 0.80 MAOA (0.66) MAOAMAOBALDH1A1HPGDCYP3A4
SCHEMBL10034861 0.78 MAOA (0.86) MAOAMAOBCYP19A1DHODH
SCHEMBL12669372 0.75 MAOA (0.62) MAOAMAOBALDH1A1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL1902938 0.74 MAOA (0.61) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL728248 0.73 MAOA (0.64) MAOAMAOBKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193353-B2 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents ROTTAPHARM S.P.A (IT) 2012-06-05 US disclosed
US-8193353-B2 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents ROTTAPHARM S.P.A (IT) 2012-06-05 US disclosed
US-20110257209-A1 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS ROTTAPHARM S.P.A (IT) 2011-10-20 US disclosed
US-20110257209-A1 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS ROTTAPHARM S.P.A (IT) 2011-10-20 US disclosed
US-7994181-B2 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents ROTTAPHARM S.P.A. (IT) 2011-08-09 US disclosed
US-7994181-B2 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents ROTTAPHARM S.P.A. (IT) 2011-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257209-A1 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS IL1A, IL6, IL1B MAOA 3149/4885MAOB 3479/4885SCN4A 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.